Catalyst Science Discovery Centre appoints director
Widnes, Cheshire-based firm welcomes Stephen Youd-Thomas
Stephen Youd-Thomas runs a successful corporate and social responsibility consultancy and was formerly head of social goals at the Co-operative Group.
‘This is a wonderful opportunity to help develop the work of the UK's only science discovery centre with chemistry as its main theme. Catalyst brings chemistry alive for thousands of young people from across the North West and beyond and hopefully this experience will encourage many of them to consider a career in science in the future,’ he said.
Catalyst is an independent charitable trust operated by Catalyst Science Discovery Centre and Museum Trust.
You may also like
Manufacturing
IMA Life-Sharp Sterile Manufacturing partnership strengthened with aseptic technology facility
Sharp's expanded facility in Massachusetts will include the installation of a fully automated IMA Life isolated filling line for Ready-To-Use (RTU) vials, addressing demand for US-based aseptic fill-finish services
Manufacturing
Cellistic launches three new iPSC-based GMP platforms to advance immuno-oncology and regenerative therapies
The three new iPSC-derived GMP manufacturing platforms, Echo-T, Echo-Cardio and Echo-Endothelial, expand the company’s Echo portfolio and are designed to improve scalability and manufacturability across immuno-oncology and regenerative medicine programmes
Manufacturing
The role of vacuum drying in battery manufacturing: From precursors to cell assembly
Lithium-ion battery manufacturers place enormous emphasis on material purity, structural integrity, and process control. Vacuum drying, used at both the precursor and electrode stages, has become an important step in achieving these performance and safety targets. Let’s explore where and how vacuum drying fits into modern battery production and how Powder Systems Ltd’s tray drying technology supports this growing need
Drug Delivery
Bio-Sourcing and Zerion Pharma secure Eurostars funding to develop HER2 oral monoclonal antibody
The pair have been awarded a €1.3m Eurostars grant to develop an oral formulation of the anti-HER2 monoclonal antibody trastuzumab for breast cancer, combining Bio-Sourcing’s BioMilk platform with Zerion’s Dispersome technology to advance the candidate through preclinical development
Manufacturing
Jubilant Biosys doubles chemistry capacity with new Noida facility in India
The company has announced the opening of a new discovery and preclinical facility in Noida, combining discovery and early-phase scale-up capabilities with R&D labs and two pilot plants to meet growing demand for FFS contracts